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Bilayer tablets of aceclofenac sodium were developed using carboxymethylated white
yam (Dioscorea rotundata) starch (CWY) for a fast release layer (2.5, 5.0, and 7.5%
w/w), and acid-hydrolyzed bitter yam (Dioscorea dumetorum) starch (ABY) for a sustaining
layer (27% w/w). Sodium starch glycolate (SSG) and hydroxypropyl methyl cellulose
(HPMC) were used as standards. The starches were characterized using Fourier Transform
Infrared spectroscopy (FT-IR), particle size, swelling power, densities and flow analyses.
Mechanical properties of the tablets were evaluated using crushing strength and friability
while release properties were evaluated using disintegration and dissolution times.
Distinctive fingerprint differences between the native andmodified starches were revealed
by FT-IR. Carboxymethylation produced starches of significantly (p < 0.05) higher swelling
and flow properties while acid-modification produced starches of higher compressibility.
Bilayer tablets containing ABY had significantly higher crushing strength and lower
friability values (p < 0.05) than those containing HPMC. Crushing strength increased while
friability values decreased with increase in CWY. Generally tablets containing the modified
Dioscorea starches gave faster (p < 0.05) disintegration times and produced an initial
burst release to provide the loading dose of the drug from the immediate-release layer
followed by sustained release (300 ± 7.56–450 ± 11.55min). The correlation coefficient
(R2) and chi-square ( 2χ ) test were employed as error analysis methods to determine the
best-fitting drug release kinetic equations. In vitro dissolution kinetics generally followed
the Higuchi and Hixson-Crowell models via a non-Fickian diffusion-controlled release.
Carboxymethylated white yam starch and acid-modified bitter yam starch could serve as
cheaper alternative excipients in bilayer tablet formulations for immediate and sustained
release of drugs respectively, particularly where high mechanical strength is required.
Keywords: aceclofenac sodium, acid-modification, bilayer tablets, carboxymethylation, Dioscorea starches,
excipients
INTRODUCTION
The cost of developing a new drugmolecule is usually high; efforts
are therefore directed at the development of new dosage forms
for existing drugs with improved safety and efficacy as well as
reduced dosing frequency and cost. Tablets are the most preferred
dosage forms for oral route of drug administration due to their
convenience, ease of dosing administration, accuracy of dosage,
flexibility in formulation, pain avoidance and patient compliance
(Banker and Anderson, 1986; Ansel et al., 2011). Conventional
monolayer tablets however have the limitations of frequent dos-
ing and unpredictable absorption window that may result in wide
range of fluctuation in drug concentration in the blood stream
and tissues, with subsequent undesirable toxicity and poor ther-
apeutic efficiency (Ansel et al., 2011). These limitations have led
Abbreviations: ABY, Acid-modified bitter yam starch; CWY, Carboxymethylated
white yam starch.
to the concept of controlled drug delivery system; even though
controlled drug delivery systems sometimes fail to achieve ade-
quate release of the initial bolus and site specific drug delivery
or may result in dose dumping. On the basis of these consider-
ations, the bi-layer tablet was proposed (Niwa et al., 2013). This
is a tablet suitable for sequential release of two drugs in combi-
nation: for the separation of two or more active pharmaceutical
ingredients (APIs) from each other and to control the release of
API from one layer by utilizing the functional property (such as
osmotic property) of the other layer. Bi-layer tablets are also suit-
able for formulating sustained release tablet in which one layer is
formulated to obtain immediate release of a drug with the aim of
reaching a high serum concentration in a short period of time,
while the second layer is designed for sustained release in order
to maintain an effective plasma level of the drug for a prolonged
period of time. The pharmacokinetic advantage relies on the fact
that drug release from fast releasing layer leads to a sudden rise
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in the blood concentration while the blood level is maintained at
steady state as the drug is released from the sustaining layer (Sharif
et al., 2011).
Various excipients have been utilized in the formulation
of bilayer tablets. For example, sodium starch glycolate (SSG)
and Hydroxypropylmethyl cellulose (HPMC) have been used
as superdisintegrants and sustained release polymer respec-
tively in the formulation of bilayer tablets of glimepride and
metformin hydrochloride (Reddy et al., 2010). In another
study, bilayer tablets of ranitidine and aceclofenac were pre-
pared using three different superdisintegrants (Crospovidone,
Croscarmellose sodium, Sodium starch glycolate) at three differ-
ent concentrations for the immediate—release layer of ranitidine
while a sustained release layer containing aceclofenac was pre-
pared using three different release-retarding polymers (Chitosan,
Xanthangum, HPMC E15) (Logidhasan et al., 2013). The imme-
diate release layer formula was observed to release 98.45% of
ranitidine HCL in 10min while the floating sustained release
formulation released 98.44% of aceclofenac in 12 h.
Inspite of the advantages bilayer tablets offer, a major challenge
is that it is more difficult to predict the long term mechani-
cal properties of these delivery systems due to poor mechanical
and compression characteristics of the constituent materials in
the compacted adjacent layers, insufficient hardness and their
tendency to delaminate at the interface between the adjacent
compacted layers during and after various stages of the for-
mulation process (Desphande et al., 2011). The use of suitable
excipients such as modified starches that can impart mechani-
cal strength to the formulation of bilayer tablets could overcome
these challenges. Yams are primary agricultural commodities
in many parts of Africa and South East Asia, classified as the
third most important tropical root crop after cassava and pota-
toes (Akoroda and Hahn, 1995). Starch obtained from Dioscorea
dumetorum (bitter yam) has been utilized as a binder at con-
centration of 2.5–10% w/w in chloroquine phosphate tablets
to produce tablets of high mechanical strength and prolonged
release in comparison to corn starch B.P., a commercial phar-
macopeia starch of well-established physico-chemical properties
(Okunlola and Odeku, 2011). When modified by acid hydrolysis,
bitter yam starches showed potential as a directly compress-
ible excipient for controlled release (Odeku and Picker-Freyer,
2009). In another study, white yam starch was shown to have
superior disintegrant properties to corn starch and bitter yam
starch (Okunlola and Odeku, 2008) when used at concentra-
tions 5–20%w/w in chloroquine phosphate tablets. White and
bitter yam starches therefore show potential as superdisintegrants
and sustained–release polymers respectively in the tablet formu-
lations. The model drug for this study is aceclofenac, molecular
formula of C16H13Cl2NO4 and mass 354.2 g/mole. It is one of
the non-steroidal anti-inflammatory drugs (NSAIDs) used in
the symptomatic treatment of rheumatoid arthritis, osteoarthri-
tis and ankylosing spondylitis. Aceclofenac is well absorbed
from the gastrointestinal tract; peak plasma concentrations are
reached 1–3 h after an oral dose (Achutha et al., 2008). The
short half-life and dosing frequency make aceclofenac an ideal
candidate for sustained release. Furthermore, reduction of dos-
ing frequency of aceclofenac will minimize the risk of serious
upper gastrointestinal effects such as bleeding, perforation and
obstruction associated with NSAIDs.
Aceclofenac sodium has previously been formulated as bilayer
tablets using mainly synthetic polymers (Karthikeyini et al., 2009;
Dey et al., 2012; Sharma et al., 2014). In this study, aceclofenac
was formulated as a bilayer tablet consisting of a fast release layer
and the sustained layer using carboxymethylated white yam starch
(CWY) and acid-hydrolyzed bitter yam starch (ABY) respec-
tively. The fast release of aceclofenac is to ensure an immediate
relief from arthritic pain, while the sustained layer ensures the
maintenance of an effective level in the body.
MATERIALS AND METHODS
MATERIALS
Aceclofenac was obtained from Indo Gulf Co., Mumbai,
India. Mono-chloroacetic acid was obtained from Alfa Aesear,
Massachusetts, USA. Sodium Starch Glycolate (SSG) was
obtained from Patel Chem Ltd, Ahmedabad, India, and
Hydroxypropylmethyl cellulose (HPMC) was obtained from
Oxford Lab Chemicals, Maharashtra, India. All other reagents
used were of analytical grade. Tubers of Dioscorea rotundata
(white yam) andDioscorea dumetorum (bitter yam)were obtained
from local farmers in Ibadan, Nigeria and authenticated at the
herbarium department of Forestry Research Institute of Nigeria,
FRIN, (FHI 109672 and 109674 respectively).
METHODS
Extraction of yam starch
The starches were extracted from the relevant yam tubers using
established methods (Young, 1984).
Modification of white yam starch
Forty grams of native yam starch was mixed with 2 g of sodium
hydroxide and 4 g of monochloroacetic acid in a beaker. One
hundred milliliters of isopropyl alcohol and 100ml of water
were added with continuous stirring to obtain homogeneity.
Subsequent reaction was allowed to proceed at 5◦C for 2 h.
Aqueous acetic acid (50% v/v) was added to the resulting mix-
ture until pH 5 was obtained. The modified starch was washed
with 80% v/v aqueous ethanol To obtain a neutral pH 7 and
then dried at 50◦C for 6 h. The dried starch was powdered,
sieved through a 120 mesh sieve (125-μm) and then stored in an
air-tight container (Singh et al., 2011).
Degree of Substitution (DS)
Modified starch (0.5 g) was dissolved in 20ml of 0.2M NaOH.
Distilled water (50ml) was added and the resulting solution was
transferred into a 100ml volumetric flask and made up to volume
with water. Twenty five milliliters of the solution was transferred
to a flask and made up to 50ml with distilled water. The excess of
NaOH was back-titrated with 0.05M Hcl using phenolphthalein
as an indicator. The titration was done in triplicates and the mean
value determined for the volume of HCl used. A blank titration
was then carried out (Stojanovic et al., 2005).
D.S. = 162 × nCOOH
(mds − 58) × nCOOH (1)
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where 162=molar mass of anhydrous glucose unit (AGU) g/mol;
mds = mass of dried sample
58 = molar mass of CH2COOH
nCOOH = (Vb - V) × CHCL × 4
Vb = volume of HCl used for titration of blank in back
titration
V = volume used in titration of sample
CHCL was concentration of HCl
4 = ratio of total volume of solution taken for titration.
Modification of bitter yam starch
Three hundred grams (dry basis) of native bitter yam starch
were hydrolysed by incubating the starch in 600ml of a 6% Hcl
solution at a temperature of 23 ± 1◦C for 192 h without stir-
ring (Atichokudomchai and Varavinit, 2003). The suspension was
neutralized with 10% w/v NaOH solution, and the starch slurry
was washed five times with distilled water and dried in a hot
air oven at 40◦C for 24 h. The starch was pulverized and then
screened through a125-μmmesh sieve.
Characterization of starch
Particle size andmorphology. The shape andmean particle size of
300 starch granules were determined using an optical microscope.
Swelling power. The swelling power of native and modified
starches was determined using the method described by Bowen
and Vadino (1984). Starch suspension (5% w/v) was prepared
at room temperature and shaken for 5min. The dispersion
was allowed to stand for 24 h before the sedimentation vol-
ume was measured and the swelling capacity was calculated.
Determinations were done in triplicates.
FT-IR analysis. The native and modified starches were analyzed
by FT-IR (FT-IR-Thermo Nicolet Nexus 870 Madison, WI, USA)
in transmission mode. Transmission spectra were recorded using
at least 64 scans with 8 cm-1 resolution in the spectral range 4000–
400 cm-1.
Determination of particle density. The particle densities of the
starches were determined by usingMultivolume pycnometer 1305
(Micromeritics Inst. Corp. Norcross Georgia, USA). The bulk
density of each starch powder at zero pressure (loose density) was
determined by pouring 10 g of the powder at an angle of 45◦C
through a funnel into a glass measuring cylinder with a diam-
eter of 21mm and a volume of 50ml. The tapped density was
measured by applying 100 taps to 10 g of each starch sample in a
graduated cylinder at a standardized rate of 38 taps per minute.
Determinations were done in triplicates.
Flowability. The flowability of the starches was assessed using the
Hausner’s ratio and the Carr’s index. The Hausner’s ratio was
determined as the ratio of the initial bulk volume to the tapped
volume while Carr’s index (% compressibility) was calculated as
follows:
Carr′s Index = tapped index − bulk density
tapped index
× 100 (2)
Angle of repose. An open ended cylinder of diameter 2.8 cm was
placed on a base of similar diameter. 30 g of starch powder was
allowed to flow through a funnel, under the force of gravity, to




Where h is the height of powder and r is the radius of the base of
the cone. The angle of repose was calculated from a mean of three
determinations.
Preparation of bi-layer tablet
Formulation of fast release layer. The fast release layer was for-
mulated by uniformly mixing aceclofenac sodium (50%w/w) with
carboxymethylated white yam starch or sodium starch glycolate
(2.5, 5.0, and 7.5% w/w), aspartame (1%w/w), colorant (1% w/w)
and microcrystalline cellulose (MCC) to 100% w/w. Magnesium
stearate (1% w/w) and talc (2% w/w) were added just before
blending.
Formulation of sustained release layer. Aceclofenac sodium sus-
tained release layer was prepared by wet granulation method.
Aceclofenac sodium (50% w/w), acid-modified bitter yam starch
or HPMC (30% w/w), Talc (0.5% w/w), magnesium stearate (1%
w/w) and Sodium carboxymethyl cellulose (in sufficient quan-
tity to make up to 100%), were passed through a sieve (250μm),
dry mixed for 5min in a planetary mixer (Model A120, Hobart
Manufacturing Co, UK) and thenmoistened with PVP (10% w/w)
dissolved in appropriate amount of isopropyl glycol to produce
granules. Massing was continued for 5min and the wet masses
were granulated by passing them manually through a mesh 12
sieve (1400μm). The granules were dried in a hot air oven at
50◦C for 18 h. Dried granules were screened through a mesh 16
sieve (1000μm) and then stored in an air-tight container.
The total dose of aceclofenac for a once-daily sustained release
formulation was calculated by the following (Karna, 2012):
Loading dose (DL) = 100mg
To calculate the maintenance dose
Dt = DL(1 + 0.693 × t/t1/2)
where Dt = Total dose of drug
Dose = dose of immediate release (100mg)
t = time (hours) during which the sustained release is
desired (8 h)
t1/2 = half-life of aceclofenac (4 h)
Dt = 100[1 + 0.693 × (8/4)] = 338.6mg = 340mg
Therefore sustained release dose = 340 − 100 = 240mg
Compression of bi-layer tablet. Granules for sustained release
layer (480mg) was compressed lightly with a predetermined load
on a Carver hydraulic press (model C, Carver Inc. Menomonee
Falls, WI) using a 10.5mm die and flat-faced punch at an ini-
tial compression pressure of 56.5 Mpa for 15 s. Over this com-
pressed layer, required quantities of formulation of the fast release
layer (200mg) was placed and final compression at 113 MNm−2
pressure for 15 s was done to form a bi-layer tablet.
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Evaluation of bi-layer tablets. Twenty tablets were selected at
random and their average weight was determined within ±1mg
(Mettler PC 440 Delta range®, CH-8606 Greifensee-Zurich,
Switzerland). Using a micrometer screw gage, the thickness of 20
tablets was measured within ±0.01mm.
The crushing strength of the tablets were determined at room
temperature by diametral compression using a tablet hardness
tester (DBK Instruments Mumbai, 400,060 model EH 01). The
results were taken only from tablets which split cleanly into two
halves without any sign of lamination. The percent friability of
the tablets was determined using a friabilator (DBK Instruments,
England) operated at 25 rpm for 4min. All measurements were
made in triplicates and the results given are the mean values.
The disintegration time of the tablets was determined in dis-
tilled water at 37 ± 0.5◦C using a disintegration tester (DBK
Instrument, England). Determinations were done in triplicates.
Ten tablets were crushed and dissolved in Phosphate buffer
pH 6.8 and assayed for drug content using a UV/Visible
Spectrophotometer (Jenway UV-7804c print, England) at wave-
length 275 nm to determine the amount of aceclofenac in the
tablets.
Dissolution test was carried out on the tablets using the
USPXX III paddle method at 100 rpm in 900ml of phosphate
buffer pH 6.8 maintained at a temperature of at 37 ± 0.5◦C
for 8 h. Samples (5ml) were withdrawn and replaced with equal
amounts of fresh medium. The sample was diluted and the
amount of aceclofenac released was determined at wavelength of
275 nmusing a UV/Visible Spectrophotometer (BeckmanCoulter
DU 730 Life Science UV/Vis Spectrophotometer USA).
The results of the drug release for the formulations was fitted to
First order (ln Qt = ln Q0+ K1t), Higuchi (Q = KH√t), Hixon-
Crowell (Q1/30 –Q
1/3
t =K t) and Korsemeyer - Peppas (Qt/Q∞=K
tn) kinetic equations (Hixson and Crowell, 1931; Higuchi, 1961;
Korsemeyer et al., 1983). The model of best fit was identified by
comparing the values of correlation coefficients and chi-square
(χ2) test.
RESULTS AND DISCUSSION
CHARACTERIZATION OF NATIVE AND MODIFIED DIOSCOREA
STARCHES
The yields of the starches of bitter and white yam were 35% and
39% respectively. Carboxymethylated white yam of degree of sub-
stitution of 0.45 was obtained. This represents the amount of
carboxymethyl groups in the molecular units of anhydrous glu-
cose. The values of mean particle size for the native and modified
starches are presented in Table 1. The native white yam starch
granules were ovoid in shape with an average particle size of
12.91 ± 5.50. Modification by carboxymethylation resulted in
larger particles of mean size 23.04±18.61μm. Bitter yam particles
were polygonal in shape with an average size of 8.53± 4.34μm
and formed aggregates on acidification to attain a greater mean
particle size of 29.74 ±14.68μm. Particle shape can influence
compaction characteristics as it is known to affect the packing
behavior of starches (Marshall, 2009).
The FT-IR spectra of the native and modified starches are
shown in Figure 1. The FT-IR spectra of carboxymethylated
starch (CWY) showed a slight modification compared to the
native form as there was a reduced intensity of the absorption
band at 3600 cm−1, due to OH stretching. This indicated that
some of the OH groups were methylated. Furthermore, there
was a sharp absorption band at about 1760 cm−1, which may be
attributed to the carbonyl groups introduced into the molecule.
The spectra of the modified bitter yam (ABY) showed a stretching
OH (3396 cm−1) and a stretching CH (2929 cm−1) absorption
bands which could be linked to acidification of alcohol groups in
the starch polysaccharides.
The values of particle density, bulk density and tap density for
the native and modified yam starches are presented in Table 1.
From the values of the bulk and tap densities, the Carr’s index
and Hausner’s ratio were calculated. The ranking of both bulk
and tapped density was ABY>CWY> native white> native bitter.
The bulk density of a starch powder describes its packing behav-
ior while the tap density indicates the rate and extent of packing
that would be experienced by the material during the various unit
operations of tableting. Higher bulk density is advantageous in
tableting because of a reduction in the fill volume of the die.
The Carr’s index is a measure of the flowability and compress-
ibility of a powder and the ranking was native white> ABY >
CWY > native bitter. The lower the Carr index the better the
flowability but the poorer the compressibility. This result indi-
cates that modification of bitter yam by acid-hydrolysis produced
starches of better compressibility. On the other hand, modifi-
cation of white yam starch by carboxymethylation resulted in
improved flowability. The Hausner’s ratio (tap to bulk density)
provides an indication of the degree of densification and the
values for the obtained for the starches were in the same rank
order.
Modification of native white by carboxymethylation resulted
in a marked increase (p < 0.05) in swelling power. This is due to
the higher hydrophilicity of the carboxyl group which takes up
more of water resulting in greater swelling. This is in contrast to
bitter yam in which acidification resulted in a decreased swelling
power due to the introduction of the more hydrophobic carbonyl
group which may have reduced its affinity for water.
Table 1 | Physical and material properties of native and modified yam starches.
Starch Particle size Particle shape Bulk density Tap density Carr Hausner Angle of Swelling
(g/cm3) (g/cm3) Index (%) ratio repose (◦) power
Native white 12.91±5.50 Ovoid 0.58 ± 0.02 0.73 ± 0.03 20.55 0.7945 57.10±3.10 1.67 ± 0.06
Carboxymethyl white 23.04±18.61 Ovoid aggregates 0.67 ± 0.00 0.80 ± 0.04 16.25 0.8375 40.50±2.90 3.35 ± 0.21
Native bitter 8.53±4.34 Polygonal 0.46 ± 0.02 0.54 ± 0.02 14.81 0.8519 51.88±2.25 1.50 ± 0.10
Acidified bitter 29.74±14.68 Polygonal aggregates 0.69 ± 0.03 0.83 ± 0.00 29.21 0.8313 57.1±3.54 1.15 ± 0.21
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FIGURE 1 | IR spectra of (A) native white yam. (B) carboxymethylated white yam starch; (C) native bitter yam and (D) acid-modified bitter yam.
Table 2 | Formulations for the immediate- and sustained-release layers of the bi-layer tablets of aceclofenac.
Fast Release Layer
Ingredient F1 (mg) F2 (mg) F3 (mg) F4 (mg) F5 (mg) F6 (mg)
Aceclofenac 100 100 100 100 100 100
Carboxymethylated white yam starch 5 10 15 – – –
Sodium starch glycollate – – – 5 10 15
Aspartame 2 2 2 2 2 2
Talc 1 1 1 1 1 1
Magnesium stearate 2 2 2 2 2 2
Microcrystalline cellulose (MCC) to 200 200 200 200 200 200
Sustained Release Layer
Ingredient S1 (mg) S2 (mg)
Aceclofenac 240 240
Acetylated bitter yam starch 144 –
HPMC – 144
PVP 48 48
Sodium carboxymethyl cellulose 40.8 40.8
Talc 2.4 2.4
Magnesium stearate 4.8 4.8
EVALUATION OF BI-LAYER TABLETS OF ACECLOFENAC
The different formulations that were used to prepare the
immediate- and sustained- release layers of the bi-layer tablets of
aceclofenac are presented in Table 2. Batches 1–12 were obtained
from combinations of the immediate and sustained layer for-
mulations and are presented in Table 3. The mechanical and
release properties of the bi-layer tablets are also presented in
Table 3. All the formulated tablets passed weight variation test
as the percentage weight variation was within the United State
Pharmacopeia limits of±5% of the weight. The average thickness
of all the formulations was found to be within the limit of speci-
fications. Generally, it was observed that formulations containing
ABY produced tablets with significantly (p < 0.05) higher crush-
ing strength than those containing HPMC. Crushing strength
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Table 3 | Mechanical and release properties of bi-layer tablets of aceclofenac (mean ± standard deviation, n = 3).
Batch Formulation Average Tablet thickness Crushing strength Friability (%) Disintegration t90 (min)
weight (g) (mm) (MNm−2) time (min)
1 F1S1 0.68 ± 0.01 5.09 ± 0.09 147.90±11.05 0.75 ± 0.02 24.00 ± 1.55 450± 11.55
2 F2S1 0.67 ± 0.01 5.05 ± 0.05 152.70±17.20 0.62 ± 0.05 25.00 ± 2.20 445± 12.20
3 F3S1 0.68 ± 0.00 5.06 ± 0.07 165.73±11.25 0.44 ± 0.10 29.00 ± 1.00 410± 10.70
4 F4S1 0.66 ± 0.00 5.05 ± 0.05 120.13±15.27 1.22 ± 0.03 27.00 ± 0.95 360± 13.95
5 F5S1 0.68 ± 0.01 5.07 ± 0.10 136.03±11.75 1.16 ± 0.08 23.00 ± 2.50 310± 8.50
6 F6S1 0.68 ± 0.01 5.03 ± 0.09 150.13±8.80 1.12 ± 0.04 28.00 ± 3.56 300± 7.56
7 F1S2 0.67 ± 0.02 5.10 ± 0.08 73.87±12.14 1.45 ± 0.06 30.00 ± 3.30 420± 13.30
8 F2S2 0.68 ± 0.02 5.09 ± 0.21 88.50±11.54 1.36 ± 0.07 33.00 ± 2.44 350± 12.44
9 F3S2 0.67 ± 0.00 5.10 ± 0.10 96.03±7.75 1.20 ± 0.08 40.00 ± 3.55 330± 9.55
10 F4S2 0.69 ± 0.01 5.08 ± 0.09 68.13±4.50 1.62 ± 0.04 36.00 ± 2.45 460± 8.45
11 F5S2 0.68 ± 0.00 5.09 ± 0.09 73.87±12.14 1.75 ± 0.06 32.00 ± 2.75 420± 8.75
12 F6S2 0.67 ± 0.002 5.11 ± 0.21 88.50±11.54 1.86 ± 0.01 40.00 ± 4.50 360± 14.50
increased with increase in CWY in all formulations. On the
other hand, tablets containing ABY generally gave significantly
(p < 0.05) lower friability values with friability values decreasing
with increase in CWY concentration. It was observed that fri-
ability was more than 1% in formulations containing SSG while
those containing CWY had lower values. Mechanical strength is
of importance in tablets as this determines the extent to which
the tablets can withstand the rigors of packaging, transportation
and handling.
The immediate release layer in all tablets disintegrated rapidly
within a period of ≤3min. it was observed that tablets contain-
ing HPMC in the sustained release layer absorbed water and were
swollen for a considerable period of time before disintegrating.
The gelling of HPMC could have retarded water penetration into
the tablets resulting in increase in disintegration times (DT) as
shown in Table 3. Generally, DT increased with concentration
and crushing strength for the tablets containing CWY as super-
disintegrant. However, for tablets containing SSG, DT appeared
to reduce with increase in concentration from 2.5 to 5%w/w and
then increased significantly (p < 0.05) when concentration was
increased to 7.5%w/w. Generally tablets containing the Dioscorea
starches gave faster disintegration times. Disintegration of tablets
play a vital role in the dissolution process since it determines to
a large extent the area of contact between the solid and liquid
(Odeku and Itiola, 2003).
Assay of drug content revealed 98.9% of aceclofenac. The plots
of cumulative drug release vs. time are shown in Figure 2. The
dissolution plots showed there was an initial rapid release of the
drug (≤40% of the total amount of aceclofenac) attributed to
the dissolution of the immediate-release portion of the bilayer
tablets. After a period of about 20min, the sustained-release por-
tion of the tablets was observed to release aceclofenac sodium
in a controlled manner. From the plots obtained, the time
taken for 90% of drug release (t90) was determined. Dissolution
times (t90) were within a range of 300 ± 7.56–4.0 ± 12.45min.
Dissolution time decreased with increase in concentrations of
the two superdisintegrants from 2.5 to 7.5%w/w for all formu-
lations. Generally, tablets containing HPMC with SSG as super-
disintegrant gave longer dissolution times than similar tablets
FIGURE 2 | Plot of cumulative percent of aceclofenac sodium released
vs. time (min).
containing CWY. HPMC in the presence of water forms a gel
which can further increase the diffusion path length of the drug.
The viscous nature of the gel can affect the diffusion coef-
ficient of the drug thereby prolonging time for drug release
(Gupta et al., 2002). Formulations containing both CWY and
ABY (formulations 1, 2, and 3) appeared to provide adequate bal-
ance between mechanical strength and adequate sustained drug
release.
The kinetics of drug release is important due to their influ-
ence on drug bioavailability. The physicochemical properties of
drug and polymer have been shown to govern the release of drug
from formulations which could also modify their release kinetics
(Nayak et al., 2010). Data obtained from in vitro release studies
were fitted to various kinetic equations to determine the kinetics
and mechanism (s) of drug release from the bilayer tablet for-
mulations. The correlation coefficient (R2) and chi-square (χ2)
test were employed as error analysis methods to determine the
best-fitting equation (Chowdhury and Das Saha, 2011) and the
results are presented in Table 4. The chi-square test appeared to
be a better method to determine the best-fitting model because
experimental values are compared with those calculated from the
model on the same abscissa and ordinate. In vitro dissolution
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Table 4 | Kinetics of in vivo release from bilayer tablets of aceclofenac sodium.
Batch First order Higuchi Hixson-Crowell Korsemeyer-
Peppas
R2 x2 R2 x2 R2 x2 R2 x2
F1S1 0.8201 1.022 0.9555 0.061 0.8557 0.000 0.7933 1.413
F2S1 0.8210 0.380 0.9685 0.195 0.9374 0.290 0.9163 0.136
F3S1 0.8728 0.043 0.9485 0.011 0.8856 0.400 0.8926 0.273
F4S1 0.8605 0.060 0.9714 0.027 0.8856 0.089 0.8422 0.455
F5S1 0.8364 0.978 0.9563 0.021 0.9029 0.011 0.8536 1.355
F6S1 0.8687 0.755 0.9711 0.055 0.9259 0.040 0.8797 1.519
F1S2 0.8446 0.309 0.9335 0.064 0.9269 0.004 0.9154 0.491
F2S2 0.7384 0.159 0.9389 0.150 0.9068 0.068 0.9272 0.998
F3S2 0.8201 0.034 0.9399 0.069 0.8557 0.386 0.9207 1.063
F4S2 0.8211 0.448 0.9470 0.080 0.9374 0.325 0.8985 0.827
F5S2 0.8730 0.322 0.9470 0.065 0.9183 0.002 0.9340 0.660
F6S2 0.8605 0.033 0.9500 0.243 0.8856 0.134 0.9255 0.994
kinetics for the bilayer tablets generally followed the Higuchi and
Hixson-Crowell models. Higuchi describes drug release as a diffu-
sion process that is square root time dependent. Hixson-Crowell
applies to pharmaceutical dosage forms, such as tablets, where
the dissolution occurs in planes that are parallel to the drug sur-
face if the tablet dimension diminishes proportionally, in such
a manner that the initial geometric form keeps constant all the
time (Costa and Sousa Lobo, 2001). Diffusion, swelling and ero-
sion are the three most important rate-controlling mechanisms
in sustained release formulations. Even though drug release from
the polymeric systems is mostly best described by fickian diffu-
sion, for certain formulations containing swelling polymers such
as HPMC, other processes include relaxation of polymer chain
and inhibition of water which causes the polymer to swell thereby
reverting from an initial glassy to a rubbery state (Ritger and
Peppas, 1987).
CONCLUSION
Formulation of bilayer tablets of aceclofenac using carboxymethy-
lated white yam starch as superdisintegrant and acidified bitter
yam starch as sustained-release polymers produced tablets of
better mechanical strength than those containing the standard
SSG and HPMC. Furthermore, tablets containing the modified
Dioscorea starches gave faster disintegration times and prolonged
drug release. Carboxymethylated white yam and acidified bit-
ter yam starches could therefore be used as alternative excipients
in the formulation of bilayer tablets of drugs that require high
mechanical strength (to minimize the problems of capping and
lamination) for immediate and sustained release of medicaments.
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